|
FDA Panel Struggles to Agree on Effectiveness of Tumor Device
An FDA advisory panel reached deadlock over the effectiveness of a novel device that blasts glioblastoma multiforme (GBM) brain tumors with an electrical field, with the panel chair breaking the tie in favor of the device.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives